BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 16327764)

  • 1. Mitochondrial tumour suppressors: a genetic and biochemical update.
    Gottlieb E; Tomlinson IP
    Nat Rev Cancer; 2005 Nov; 5(11):857-66. PubMed ID: 16327764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer.
    King A; Selak MA; Gottlieb E
    Oncogene; 2006 Aug; 25(34):4675-82. PubMed ID: 16892081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree?
    Bayley JP; Devilee P
    Curr Opin Genet Dev; 2010 Jun; 20(3):324-9. PubMed ID: 20304625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of paragangliomas: a review.
    Martin TP; Irving RM; Maher ER
    Clin Otolaryngol; 2007 Feb; 32(1):7-11. PubMed ID: 17298303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell-type-specificity of inherited predispositions to tumours: review and hypothesis.
    Bignold LP
    Cancer Lett; 2004 Dec; 216(2):127-46. PubMed ID: 15533589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The difference between benign and malignant tumours explained with the 4-mutation paradigm for carcinogenesis.
    Koten JW; Neijt JP; Zonnenberg BA; Den Otter W
    Anticancer Res; 1993; 13(4):1179-82. PubMed ID: 8352541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
    BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.
    Pollard PJ; Brière JJ; Alam NA; Barwell J; Barclay E; Wortham NC; Hunt T; Mitchell M; Olpin S; Moat SJ; Hargreaves IP; Heales SJ; Chung YL; Griffiths JR; Dalgleish A; McGrath JA; Gleeson MJ; Hodgson SV; Poulsom R; Rustin P; Tomlinson IP
    Hum Mol Genet; 2005 Aug; 14(15):2231-9. PubMed ID: 15987702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel germline mutations in the SDHB and SDHD genes in Japanese pheochromocytomas.
    Isobe K; Minowada S; Tatsuno I; Suzukawa K; Nissato S; Nanmoku T; Hara H; Yashiro T; Kawakami Y; Takekoshi K
    Horm Res; 2007; 68(2):68-71. PubMed ID: 17308434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumours of familial origin in the head and neck.
    Suárez C; Rodrigo JP; Ferlito A; Cabanillas R; Shaha AR; Rinaldo A
    Oral Oncol; 2006 Nov; 42(10):965-78. PubMed ID: 16857415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes.
    Benn DE; Richardson AL; Marsh DJ; Robinson BG
    Ann N Y Acad Sci; 2006 Aug; 1073():104-11. PubMed ID: 17102077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant head and neck paragangliomas in SDHB mutation carriers.
    Boedeker CC; Neumann HP; Maier W; Bausch B; Schipper J; Ridder GJ
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):126-9. PubMed ID: 17599579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cells silenced for SDHB expression display characteristic features of the tumor phenotype.
    Cervera AM; Apostolova N; Crespo FL; Mata M; McCreath KJ
    Cancer Res; 2008 Jun; 68(11):4058-67. PubMed ID: 18519664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial mutations in cancer.
    Brandon M; Baldi P; Wallace DC
    Oncogene; 2006 Aug; 25(34):4647-62. PubMed ID: 16892079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.
    Persu A; Hamoir M; Grégoire V; Garin P; Duvivier E; Reychler H; Chantrain G; Mortier G; Mourad M; Maiter D; Vikkula M
    J Hypertens; 2008 Jul; 26(7):1395-401. PubMed ID: 18551016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas.
    Klein RD; Jin L; Rumilla K; Young WF; Lloyd RV
    Diagn Mol Pathol; 2008 Jun; 17(2):94-100. PubMed ID: 18382370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the C. elegans succinate dehydrogenase iron-sulfur subunit promote superoxide generation and premature aging.
    Huang J; Lemire BD
    J Mol Biol; 2009 Apr; 387(3):559-69. PubMed ID: 19233206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of p53, p63, and p73 to the developmental diseases and cancer.
    Tomkova K; Tomka M; Zajac V
    Neoplasma; 2008; 55(3):177-81. PubMed ID: 18348649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular progress in hereditary paraganglioma.
    Baysal BE
    J Med Genet; 2008 Nov; 45(11):689-94. PubMed ID: 18978332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
    Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
    Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.